Journal article
Antibodies against hypocretin receptor 2 are rare in narcolepsy
- Abstract:
-
Study Objectives
Recently, antibodies to the hypocretin receptor 2 (HCRTR2-Abs) were reported in a high proportion of narcolepsy patients who developed the disease following Pandemrix® vaccination. We tested a group of narcolepsy patients for the HCRTR2-Abs using a newly established cell-based assay.
Methods
Sera from 50 narcolepsy type 1 (NT1) and 11 narcolepsy type 2 (NT2) patients, 22 patients with other sleep disorders, 15 healthy controls, and 93 disease cont...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
European Academy of Neurology
More from this funder
Bibliographic Details
- Publisher:
- Oxford University Press Publisher's website
- Journal:
- Sleep Journal website
- Volume:
- 40
- Issue:
- 2
- Pages:
- zsw056
- Publication date:
- 2016-12-10
- Acceptance date:
- 2016-10-01
- DOI:
- EISSN:
-
1550-9109
- ISSN:
-
0161-8105
- Pmid:
-
28364500
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:686140
- UUID:
-
uuid:4d158dc4-5882-453c-84cd-cdf86ba6ca7a
- Local pid:
- pubs:686140
- Deposit date:
- 2018-11-13
Terms of use
- Copyright holder:
- Sleep Research Society
- Copyright date:
- 2016
- Notes:
- © Sleep Research Society 2016. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com. This is the accepted manuscript version of the article. The final version is available online from Oxford University Press at: https://doi.org/10.1093/sleep/zsw056
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record